Aakanksha Angra: Building a Community for Advances in ALL
Aakanksha Angra, Senior Manager, Learning Scientist at American Society of Hematology, shared ASH’s post on LinkedIn:
”The Acute Lymphoblastic Leukemia (ALL) landscape is complex and constantly evolving.
For community clinicians without built-in resources, keeping up can feel isolating.
ALL ASH Connections was built to change that- live QAs, discussion boards, and a peer community that helps you stay informed and connected.
Our first interactive case on MRD-Guided Escalation in Pediatric B-ALL goes live May 18, 2026 at 12 PM, EST.
Our first virtual live Q&A hosted by Drs. Rabi Hanna and Jennifer McNeer will be on June 2nd from 10-11 AM, EST.”
ASH Education shared a post on LinkedIn:
”Calling all healthcare providers!
The American Society of Hematology invites you to join the ALL (Acute Lymphoblastic Leukemia) community on ASH Connections, a disease-focused space where you can engage with case-based scenarios, join discussion boards, and participate in live QA sessions with experts. No ASH membership required.
Spread the word!
Visit to join the ALL Community today!”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics
-
Nov 14, 2026, 23:33Alexandros Makis: Exploring Vascular Mechanisms and Therapeutic Targets in β-Thalassemia